4-Fluoro-N-[2-[4-(2-Methoxyphenyl)Piperazin-1-Yl]Ethyl]-N-Pyridin-2-Ylbenzamide

2 trials 2 recruiting

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

2 Recruiting

0 Completed trials

2 Sponsors

1 Countries

Phase II

Phase II: 2

Sponsors using this IMP

Centre Hospitalier Universitaire De Nantes 1 Hospices Civils De Lyon 1

All trials

2 total

A PET-MRI study of serotoninergic brainstem pathway in patients with Dravet Syndrome - DRAPETONINE Recruiting

2025-524199-40-00 Phase II 1 country Hospices Civils De Lyon
Pathophysiology of pain in Parkinson's disease: exploration of the serotonin system in positron emission tomography Recruiting

2022-501123-24-00 Phase II 1 country Centre Hospitalier Universitaire De Toulouse

Showing 1–2 of 2 trials

← All drugs A–Z